Apollo, CPP Investments Receive Approval by EU Commission for Acquisition of Novolex, Pactiv

MT Newswires Live
06 Mar

Apollo Capital Management (APO) and Canada Pension Plan Investment Board's acquisition of joint control of Novolex and Pactiv Evergreen (PTVE) was approved by the European Commission, the regulator said Thursday.

The transaction, which primarily concerns the manufacturing of paper and plastic consumer packaging, would not raise competition concerns given the limited combined market position, the European Commission determined.

The transaction was reviewed under the simplified merger review procedure.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10